Serotonin, tryptophan metabolism and the brain-gut-microbiome axis

Behavioural Brain Research

Volumn 277, Issue , 2015, Pages 32-48

  O'Mahony, S M ^a,b   Clarke, G ^a,b   Borre, Y E ^a   Dinan, T G ^a,b   Cryan, J F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Anxiety; Kynurenine; Microbiome; Pain; Serotonin; Tryptophan

Indexed keywords

KYNURENINE; NEUROTRANSMITTER; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE;

BACTERIAL STRAIN; BRAIN GUT MICROBIOME; CENTRAL NERVOUS SYSTEM; COGNITION; GASTROINTESTINAL TRACT; HUMAN; IMMUNE FUNCTION TEST; INTESTINE FLORA; INTESTINE INNERVATION; METABOLITE; MICROBIAL COLONIZATION; MICROBIOME; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; REVIEW; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; TRYPTOPHAN METABOLISM; ANIMAL; BEHAVIOR; BRAIN; METABOLISM; MICROFLORA; PHYSIOLOGY;

ANIMALS; BEHAVIOR; BRAIN; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; SEROTONIN; TRYPTOPHAN;

EID: 84912141027     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.07.027     Document Type: Review

References (247)

1. Berger M., Gray J.A., Roth B.L. The expanded biology of serotonin. Ann Rev Med 2009, 60:355-366.
2. Schwarcz R., Bruno J.P., Muchowski P.J., Wu H.Q. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 2012, 13:465-477.
3. Le Floc'h N., Otten W., Merlot E. Tryptophan metabolism, from nutrition to potential therapeutic applications. Amino Acids 2011, 41:1195-1205.
4. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011, 12:453-466.
5. Rhee S.H., Pothoulakis C., Mayer E.A. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nature Rev 2009, 6:306-314.
6. Mawe G.M., Hoffman J.M. Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nature Rev 2013, 10:473-486.
7. Collins S.M., Surette M., Bercik P. The interplay between the intestinal microbiota and the brain. Nature Rev Microbiol 2012, 10:735-742.
8. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012, 13:701-712.
9. Cryan J.F., O'Mahony S.M. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011, 23:187-192.
10. Grenham S., Clarke G., Cryan J.F., Dinan T.G. Brain-gut-microbe communication in health and disease. Front Physiol 2011, 2:94.
11. Ruddick J.P., Evans A.K., Nutt D.J., Lightman S.L., Rook G.A., Lowry C.A. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med 2006, 8:1-27.
12. Fernstrom J.D. Effects and side effects associated with the non-nutritional use of tryptophan by humans. J Nutr 2012, 142:2236S-2244S.
13. Csapo J., Salamon S. Composition of the mother's milk I. Protein contents, amino acid composition, biological value. A review. Acta Univ Sapientiae, Alimentaria 2009, 2:174-195.
14. Fernstrom J.D., Fernstrom M.H. Exercise, serum free tryptophan, and central fatigue. J Nutr 2006, 136:553S-559S.
15. Spiller R. Serotonin and GI clinical disorders. Neuropharmacology 2008, 55:1072-1080.
16. Gershon M.D. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obesity 2013, 20:14-21.
17. Vecsei L., Szalardy L., Fulop F., Toldi J. Kynurenines in the CNS: recent advances and new questions. Nature Rev Drug Discov 2013, 12:64-82.
18. Stone T.W., Forrest C.M., Darlington L.G. Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection. FEBS J 2012, 279:1386-1397.
19. Braidy N., Grant R., Adams S., Brew B.J., Guillemin G.J. Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotox Res 2009, 16:77-86.
20. Szalardy L., Zadori D., Toldi J., Fulop F., Klivenyi P., Vecsei L. Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction. Curr Top Med Chem 2012, 12:1797-1806.
21. Albuquerque E.X., Schwarcz R. Kynurenic acid as an antagonist of alpha7 nicotinic acetylcholine receptors in the brain: facts and challenges. Biochem Pharmacol 2013, 85:1027-1032.
22. Turski M.P., Turska M., Paluszkiewicz P., Parada-Turska J., Oxenkrug G.F. Kynurenic acid in the digestive system-new facts, new challenges. Int J Tryptophan Res: IJTR 2013, 6:47-55.
23. Raison C.L., Dantzer R., Kelley K.W., Lawson M.A., Woolwine B.J., Vogt G., et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 2010, 15:393-403.
24. Maes M., Leonard B.E., Myint A.M., Kubera M., Verkerk R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuro-psychopharmacol Biol Psychiatry 2011, 35:702-721.
25. Fernstrom J.D., Langham K.A., Marcelino L.M., Irvine Z.L., Fernstrom M.H., Kaye W.H. The ingestion of different dietary proteins by humans induces large changes in the plasma tryptophan ratio, a predictor of brain tryptophan uptake and serotonin synthesis. Clin Nutr 2013, 32:1073-1076.
26. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., Heninger G.R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990, 47:411-418.
27. Young S.N. Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects. J Psychiatry Neurosci: JPN 2013, 38:294-305.
28. Hood S.D., Bell C.J., Nutt D.J. Acute tryptophan depletion. Part I: rationale and methodology. The Aust New Zealand J Psychiatry 2005, 39:558-564.
29. Weinstock G.M. Genomic approaches to studying the human microbiota. Nature 2012, 489:250-256.
30. Lozupone C.A., Stombaugh J.I., Gordon J.I., Jansson J.K., Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489:220-230.
31. Rajilic-Stojanovic M., de Vos W.M. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 2014.
32. Clarke G., O' Mahony S.M., Dinan Timothy G., Cryan J.F. Priming for health: the gut microbiota acquired early in life regulates physiology, brain and behaviour. Acta Paediatrica 2014, 103(8):812-819. [Epub 2014 May 17]. 10.1111/apa.12674.
33. Borre Y.E., O'Keeffe G.W., Clarke G., Stanton C., Dinan T.G., Cryan J.F. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 2014, pii: S1471-4914(14)00081-1, [Epub ahead of print] Review. PMID: 24956966. 10.1016/j.molmed.2014.05.002.
34. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010, 107:11971-11975.
35. Parfrey L.W., Knight R. Spatial and temporal variability of the human microbiota. Clin Microbiol Infect Official Publicat Euro Soc Clin Microbiol Infect Dis 2012, 18(Suppl. 4):8-11.
36. Penders J., Thijs C., Vink C., Stelma F.F., Snijders B., Kummeling I., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118:511-521.
37. Barrett E., Guinane C.M., Ryan C.A., Dempsey E.M., Murphy B.P., O'Toole P.W., et al. Microbiota diversity and stability of the preterm neonatal ileum and colon of two infants. Microbiol Open 2013, 2:215-225.
38. Zivkovic A.M., German J.B., Lebrilla C.B., Mills D.A. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci USA 2011, 108(Suppl 1):4653-4658.
39. Azad M.B., Konya T., Maughan H., Guttman D.S., Field C.J., Chari R.S., et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ: Canad Med Assoc J (Journal de l'Association medicale canadienne) 2013, 185:385-394.
40. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
41. Wall R., Ross R.P., Ryan C.A., Hussey S., Murphy B., Fitzgerald G.F., et al. Role of gut microbiota in early infant development. Clin Med Pediatr 2009, 3:45-54.
42. Saavedra J.M. Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects. Nutr Clin Practice: Off Publicat Am Soc Parenteral Enteral Nutr 2007, 22:351-365.
43. Douglas-Escobar M., Elliott E., Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr 2013, 167:374-379.
44. A framework for human microbiome research. Nature. 2012;486:215-21.
45. Turnbaugh P.J., Gordon J.I. The core gut microbiome, energy balance and obesity. J Physiol 2009, 587:4153-4158.
46. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
47. David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2013.
48. Relman D.A. The human microbiome: ecosystem resilience and health. Nutr Rev 2012, 70(Suppl. 1):S2-S9.
49. Dethlefsen L., Relman D.A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011, 108(Suppl. 1):4554-4561.
50. Claesson M.J., Cusack S., O'Sullivan O., Greene-Diniz R., de Weerd H., Flannery E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 2011, 108(Suppl. 1):4586-4591.
51. Claesson M.J., Jeffery I.B., Conde S., Power S.E., O'Connor E.M., Cusack S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488:178-184.
52. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nature Rev Neurosci 2009, 10:434-445.
53. Fidalgo S., Ivanov D.K., Wood S.H. Serotonin: from top to bottom. Biogerontology 2013, 14:21-45.
54. Williams S.C. Gnotobiotics. Proc Natl Acad Sci USA 2014, 111:1661.
55. Clarke G., Grenham S., Scully P., Fitzgerald P., Moloney R.D., Shanahan F., et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2013, 18:666-673.
56. Heijtz R.D., Wang S., Anuar F., Qian Y., Bjorkholm B., Samuelsson A., et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011, 108:3047-3052.
57. Wikoff W.R., Anfora A.T., Liu J., Schultz P.G., Lesley S.A., Peters E.C., et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009, 106:3698-3703.
58. Sarrias M.J., Martinez E., Celada P., Udina C., Alvarez E., Artigas F. Plasma free 5HT and platelet 5HT in depression: case-control studies and the effect of antidepressant therapy. Adv Exp Med Biol 1991, 294:653-658.
59. El Aidy S., Kunze W., Bienenstock J., Kleerebezem M. The microbiota and the gut-brain axis: insights from the temporal and spatial mucosal alterations during colonisation of the germfree mouse intestine. Beneficial Microb 2012, 3:251-259.
60. Crumeyrolle-Arias V., Jaglind V., Bruneaud A., Vancasself S., Cardona A., Daugé V., et al. Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology 2014, http://dx.doi.org/10.1016/j.psyneuen.2014.01.014.
61. Desbonnet L., Garrett L., Clarke G., Bienenstock J., Dinan T.G. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatric Res 2008, 43:164-174.
62. Bercik P., Verdu E.F., Foster J.A., Macri J., Potter M., Huang X., et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010, 139. 2102-12 e1.
63. Valladares R., Bojilova L., Potts A.H., Cameron E., Gardner C., Lorca G., et al. Lactobacillus johnsonii inhibits indoleamine 2,3-dioxygenase and alters tryptophan metabolite levels in BioBreeding rats. FASEB J: Off Publ Federation Am Soc Exp Biol 2013, 27:1711-1720.
64. Freewan M., Rees M.D., Plaza T.S., Glaros E., Lim Y.J., Wang X.S., et al. Human indoleamine 2,3-dioxygenase is a catalyst of physiological heme peroxidase reactions: implications for the inhibition of dioxygenase activity by hydrogen peroxide. J Biol Chem 2013, 288:1548-1567.
65. Tomas M.S., Claudia Otero M., Ocana V., Elena Nader-Macias M. Production of antimicrobial substances by lactic acid bacteria I: determination of hydrogen peroxide. Methods Mol Biol 2004, 268:337-346.
66. MacKenzie C.R., Heseler K., Muller A., Daubener W. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr Drug Metab 2007, 8:237-244.
67. Clarke G., Quigley E.M., Cryan J.F., Dinan T.G. Irritable bowel syndrome: towards biomarker identification. Trends Mol Med 2009, 15:478-489.
68. Clarke G., Fitzgerald P., Cryan J.F., Cassidy E.M., Quigley E.M., Dinan T.G. Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol 2009, 9:6.
69. Clarke G., McKernan D.P., Gaszner G., Quigley E.M., Cryan J.F., Dinan T.G. A distinct profile of tryptophan metabolism along the kynurenine pathway downstream of toll-like receptor activation in irritable bowel syndrome. Front Pharmacol 2012, 3:90.
70. Fitzgerald P., Cassidy Eugene M., Clarke G., Scully P., Barry S., Quigley Eamonn M.M., et al. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterol Motil 2008, 20:1291-1297.
71. Brint E.K., MacSharry J., Fanning A., Shanahan F., Quigley E.M. Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol 2011, 106:329-336.
72. McKernan D.P., Gaszner G., Quigley E.M., Cryan J.F., Dinan T.G. Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment Pharmacol Ther 2011, 33:1045-1052.
73. McKernan D.P., Nolan A., Brint E.K., O'Mahony S.M., Hyland N.P., Cryan J.F., et al. Toll-like receptor mRNA expression is selectively increased in the colonic mucosa of two animal models relevant to irritable bowel syndrome. PLoS One 2009, 4:e8226.
74. Schroecksnadel K., Winkler C., Wirleitner B., Schennach H., Fuchs D. Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro. Clin Exp Immunol 2005, 140:41-45.
75. Schroecksnadel S., Sucher R., Kurz K., Fuchs D., Brandacher G. Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells. Transplant Immunol 2011, 25:119-123.
76. Milligan T.W., Doran T.I., Straus D.C., Mattingly S.J. Growth and amino acid requirements of various strains of group B streptococci. J Clin Microbiol 1978, 7:28-33.
77. Li G., Young K.D. Indole production by the tryptophanase TnaA in Escherichia coli is determined by the amount of exogenous tryptophan. Microbiology 2013, 159:402-410.
78. Lee J.H., Lee J. Indole as an intercellular signal in microbial communities. FEMS Microbiol Rev 2010, 34:426-444.
79. Hsiao E.Y. Immune dysregulation in autism spectrum disorder. Int Rev Neurobiol 2013, 113:269-302.
80. Lambrecht M., Okon Y., Vande Broek A., Vanderleyden J. Indole-3-acetic acid: a reciprocal signalling molecule in bacteria-plant interactions. Trends Microbiol 2000, 8:298-300.
81. Raboni S., Bettati S., Mozzarelli A. Tryptophan synthase: a mine for enzymologists. Cellular Mol Life Sci: CMLS 2009, 66:2391-2403.
82. Yanofsky C. RNA-based regulation of genes of tryptophan synthesis and degradation, in bacteria. Rna 2007, 13:1141-1154.
83. Jimenez E., Ladero V., Chico I., Maldonado-Barragan A., Lopez M., Martin V., et al. Antibiotic resistance, virulence determinants and production of biogenic amines among enterococci from ovine, feline, canine, porcine and human milk. BMC Microbiol 2013, 13:288.
84. Lyte M. Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics. Bioessays 2011, 33:574-581.
85. Shishov V.A., Kirovskaia T.A., Kudrin V.S., Oleskin A.V. [Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12]. Prikladnaia biokhimiia i mikrobiologiia 2009, 45:550-554.
86. Munoz-Bellido J.L., Munoz-Criado S., Garcia-Rodriguez J.A. Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors. Int J Antimicrobial Agents 2000, 14:177-180.
87. Bonnin A., Levitt P. Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 2011, 197:1-7.
88. Nasyrova D.I., Sapronova A., Balbashev A.V., Kudrin V.S., Klodt P.M., Raevskii K.S., et al. [Development of central and peripheral serotonin-producing systems in rats in ontogenesis]. Zh Evol Biokhim Fiziol 2009, 45:68-74.
89. Clarke G., O'Mahony S.M., Dinan T.G., Cryan J.F. Priming for health: the gut microbiota acquired early in life regulates physiology. Brain Behav Acta Paediatrica 2014, In Press.
90. Levitt P. Structural and functional maturation of the developing primate brain. J Pediatr 2003, 143:S35-S45.
91. Ugrumov M.V. Developing brain as an endocrine organ: a paradoxical reality. Neurochem Res 2010, 35:837-850.
92. Migliarini S., Pacini G., Pelosi B., Lunardi G., Pasqualetti M. Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Mol Psychiatry 2013, 18:1106-1118.
93. Rice D., Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000, 108(Suppl 3):511-533.
94. Dobbing J., Sands J. Quantitative growth and development of human brain. Arch Dis Child 1973, 48:757-767.
95. Saunders N.R., Liddelow S.A., Dziegielewska K.M. Barrier mechanisms in the developing brain. Front Pharmacol 2012, 3:46.
96. MacFabe D.F. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrumdisorders. Microbial Ecol Health Dis 2012, 23:1-24.
97. Clarke G., Stilling R.M., Kennedy P.J., Stanton C., Cryan J.F., Dinan T.G., Gut Microbiota: 1. Gut microbiota: the neglected endocrine organ. Mol Endocrinol 2014, me20141108.
98. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998, 44:151-162.
99. Ulloa R.E., Diaz-Valderrama A., Herrera-Perez J., Leon-Olea M., Martinez-Mota L. Age differences in the impact of forced swimming test on serotonin transporter levels in lateral septum and dorsal raphe. Behav Brain Funct 2014, 10:3.
100. Briscoe J., Sussel L., Serup P., Hartigan-O'Connor D., Jessell T.M., Rubenstein J.L., et al. Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling. Nature 1999, 398:622-627.
101. Murrin L.C., Sanders J.D., Bylund D.B. Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. Biochem Pharmacol 2007, 73:1225-1236.
102. Tissari A.H. Pharmacological and ultrastructural maturation of serotonergic synapses during ontogeny. Med Biol 1975, 53:1-14.
103. Makkonen I., Riikonen R., Kokki H., Airaksinen M.M., Kuikka J.T. Serotonin and dopamine transporter binding in children with autism determined by SPECT. Dev Med Child Neurol 2008, 50:593-597.
104. Yamamoto M., Suhara T., Okubo Y., Ichimiya T., Sudo Y., Inoue M., et al. Age-related decline of serotonin transporters in living human brain of healthy males. Life Sci 2002, 71:751-757.
105. Kiyasova V., Gaspar P. Development of raphe serotonin neurons from specification to guidance. Eur J Neurosci 2011, 34:1553-1562.
106. Amaral F.A., Sachs D., Costa V.V., Fagundes C.T., Cisalpino D., Cunha T.M., et al. Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci USA 2008, 105:2193-2197.
107. Neufeld K.M., Kang N., Bienenstock J., Foster J.A. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2010, 23:255-264. e119.
108. Morgan D.G. The dopamine and serotonin systems during aging in human and rodent brain. A brief review. Prog Neuropsychopharmacol Biol Psychiatry 1987, 11:153-157.
109. Branchek T.A., Gershon M.D. Time course of expression of neuropeptide Y, calcitonin gene-related peptide, and NADPH diaphorase activity in neurons of the developing murine bowel and the appearance of 5-hydroxytryptamine in mucosal enterochromaffin cells. J Comp Neurol 1989, 285:262-273.
110. Zhao H., Sovadinova I., Swope V.M., Swain G.M., Kadrofske M.M., Bian X. Postnatal development of the serotonin signaling system in the mucosa of the guinea pig ileum. Neurogastroenterol Motil 2011, 23:161-168. e40.
111. Britton E., McLaughlin J.T. Ageing and the gut. Proc Nutr Soc 2013, 72:173-177.
112. Lake J.I., Heuckeroth R.O. Enteric nervous system development: migration, differentiation, and disease. Am J Physiol Gastrointest Liver Physiol 2013, 305:G1-G24.
113. Burns A.J., Pachnis V. Development of the enteric nervous system: bringing together cells, signals and genes. Neurogastroenterol Motil 2009, 21:100-102.
114. Metzger M. Neurogenesis in the enteric nervous system. Arch Ital Biol 2010, 148:73-83.
115. Gershon M.D. The play is still being written on opening day: postnatal maturation of enteric neurons may provide an opening for early life mischief. J Physiol 2012, 590:2185-2186.
116. Pham T.D., Gershon M.D., Rothman T.P. Time of origin of neurons in the murine enteric nervous system: sequence in relation to phenotype. J Comp Neurol 1991, 314:789-798.
117. Gross E.R., Gershon M.D., Margolis K.G., Gertsberg Z.V., Li Z., Cowles R.A. Neuronal serotonin regulates growth of the intestinal mucosa in mice. Gastroenterology 2012, 143. 408-17 e2.
118. Liu M.T., Kuan Y.H., Wang J., Hen R., Gershon M.D. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 2009, 29:9683-9699.
119. Fiorica-Howells E., Maroteaux L., Gershon M.D. Serotonin and the 5-HT(2B) receptor in the development of enteric neurons. J Neurosci 2000, 20:294-305.
120. Lavdas A.A., Blue M.E., Lincoln J., Parnavelas J.G. Serotonin promotes the differentiation of glutamate neurons in organotypic slice cultures of the developing cerebral cortex. J Neurosci 1997, 17:7872-7880.
121. Saffrey M.J. Cellular changes in the enteric nervous system during ageing. Dev Biol 2013, 382:344-355.
122. Saffrey M.J. Aging of the mammalian gastrointestinal tract: a complex organ system. Age (Dordr) 2013.
123. Gershon M.D. Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. Trans Am Clin Climatol Assoc 2012, 123:268-280. discussion 80.
124. Nakamura K., Sato T., Ohashi A., Tsurui H., Hasegawa H. Role of a serotonin precursor in development of gut microvilli. Am J Pathol 2008, 172:333-344.
125. Di Mauro A., Neu J., Riezzo G., Raimondi F., Martinelli D., Francavilla R., et al. Gastrointestinal function development and microbiota. Ital J Pediatr 2013, 39:15.
126. Holsapple M.P., West L.J., Landreth K.S. Species comparison of anatomical and functional immune system development. Birth Defects Res B Dev Reprod Toxicol 2003, 68:321-334.
127. Battersby A.J., Gibbons D.L. The gut mucosal immune system in the neonatal period. Pediatr Allergy Immunol Off Publ Euro Soc Pediatr Allergy Immunol 2013, 24:414-421.
128. Kaplan J.L., Shi H.N., Walker W.A. The role of microbes in developmental immunologic programming. Pediatr Res 2011, 69:465-472.
129. Bauer E., Williams B.A., Smidt H., Verstegen M.W., Mosenthin R. Influence of the gastrointestinal microbiota on development of the immune system in young animals. Curr Issues Intest Microbiol 2006, 7:35-51.
130. Tsai Y.T., Cheng P.C., Pan T.M. The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol 2012, 96:853-862.
131. Bennet R., Eriksson M., Nord C.E. The fecal microflora of 1-3-month-old infants during treatment with eight oral antibiotics. Infection 2002, 30:158-160.
132. Marra F., Lynd L., Coombes M., Richardson K., Legal M., FitzGerald J.M., et al. Does antibiotic exposure during infancy lead to development of asthma?. A systematic review and metaanalysis 2006. Chest 2009, 136:e30.
133. Murk W., Risnes K.R., Bracken M.B. Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review. Pediatrics 2011, 127:1125-1138.
134. Shaw S.Y., Blanchard J.F., Bernstein C.N. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 2010, 105:2687-2692.
135. Spiller R. Serotonin, inflammation, and IBS: fitting the jigsaw together?. J Pediatr Gastroenterol Nutr 2007, 45(Suppl. 2):S115-S119.
136. Cloez-Tayarani I., Changeux J.P. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol 2007, 81:599-606.
137. Stefulj J., Cicin-Sain L., Schauenstein K., Jernej B. Serotonin and immune response: effect of the amine on in vitro proliferation of rat lymphocytes. Neuroimmunomodulation 2001, 9:103-108.
138. Khan W.I., Ghia J.E. Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol 2010, 161:19-27.
139. Bishop A.E., Pietroletti R., Taat C.W., Brummelkamp W.H., Polak J.M. Increased populations of endocrine cells in Crohn's ileitis. Virchows Arch A Pathol Anat Histopathol 1987, 410:391-396.
140. Coates M.D., Mahoney C.R., Linden D.R., Sampson J.E., Chen J., Blaszyk H., et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004, 126:1657-1664.
141. El-Salhy M., Danielsson A., Stenling R., Grimelius L. Colonic endocrine cells in inflammatory bowel disease. J Intern Med 1997, 242:413-419.
142. Stasi C., Bellini M., Bassotti G., Blandizzi C., Milani S. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech Coloproctol 2014.
143. Ford A.C., Talley N.J., Schoenfeld P.S., Quigley E.M., Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009, 58:367-378.
144. Khan W.I., Motomura Y., Wang H., El-Sharkawy R.T., Verdu E.F., Verma-Gandhu M., et al. Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol 2006, 291:G803-G811.
145. O'Hara J.R., Skinn A.C., MacNaughton W.K., Sherman P.M., Sharkey K.A. Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell Microbiol 2006, 8:646-660.
146. Wheatcroft J., Wakelin D., Smith A., Mahoney C.R., Mawe G., Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005, 17:863-870.
147. Ghia J.E., Li N., Wang H., Collins M., Deng Y., El-Sharkawy R.T., et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 2009, 137:1649-1660.
148. Ratcliffe E.M., Farrar N.R., Fox E.A. Development of the vagal innervation of the gut: steering the wandering nerve. Neurogastroenterol Motil Off J Euro Gastrointestinal Motil Soc 2011, 23:898-911.
149. Lomasney K.W., Houston A., Shanahan F., Dinan T.G., Cryan J.F., Hyland N.P. Selective influence of host microbiota on cAMP-mediated ion transport in mouse colon. Neurogastroenterol Motil 2014.
150. Sommer F., Backhed F. The gut microbiota--masters of host development and physiology. Nature Rev Microbiol 2013, 11:227-238.
151. Raabe F.J., Spengler D. Epigenetic risk factors in PTSD and depression. Front Psychiatry 2013, 4:80.
152. Gunnar M.R., Donzella B. Social regulation of the cortisol levels in early human development. Psychoneuroendocrinology 2002, 27:199-220.
153. Axelrod J., Reisine T.D. Stress hormones: their interaction and regulation. Science (New York, NY) 1984, 224:452-459.
154. de Diego A.M., Gandia L., Garcia A.G. A physiological view of the central and peripheral mechanisms that regulate the release of catecholamines at the adrenal medulla. Acta Physiolog 2008, 192:287-301.
155. Young J.B. Programming of sympathoadrenal function. Trends Endocrinol Metab TEM 2002, 13:381-385.
156. Dinan T.G., Cryan J.F. Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinology. Psychoneuroendocrinology 2012.
157. Bhatia V., Tandon R.K. Stress and the gastrointestinal tract. J Gastroenterol Hepatol 2005, 20:332-339.
158. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacolog Rev 2000, 52:595-638.
159. O'Mahony S.M., Hyland N.P., Dinan T.G., Cryan J.F. Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology (Berl) 2011, 214:71-88.
160. Tannock G.W., Savage D.C. Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract. Infect Immun 1974, 9:591-598.
161. O'Mahony S.M., Marchesi J.R., Scully P., Codling C., Ceolho A.M., Quigley E.M., et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 2009, 65:263-267.
162. Bailey M.T., Coe C.L. Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev Psychobiol 1999, 35:146-155.
163. Sudo N., Chida Y., Aiba Y., Sonoda J., Oyama N., Yu X.N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004, 558:263-275.
164. Ohta K., Miki T., Warita K., Suzuki S., Kusaka T., Yakura T., et al. Prolonged maternal separation disturbs the serotonergic system during early brain development. Int J Dev Neurosci 2014, 33:15-21.
165. Ren T.H., Wu J., Yew D., Ziea E., Lao L., Leung W.K., et al. Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2007, 292:G849-G856.
166. Bercik P., Denou E., Collins J., Jackson W., Lu J., Jury J., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011, 141. 599-609.e3.
167. Goehler L.E., Park S.M., Opitz N., Lyte M., Gaykema R.P. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav Immun 2008, 22:354-366.
168. Lyte M., Li W., Opitz N., Gaykema R., Goehler L.E. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 2006, 89:350-357.
169. Lyte M., Varcoe J.J., Bailey M.T. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav 1998, 65:63-68.
170. Bercik P., Park A.J., Sinclair D., Khoshdel A., Lu J., Huang X., et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011, 23:1132-1139.
171. Gross C., Hen R. The developmental origins of anxiety. Nat Rev Neurosci 2004, 5:545-552.
172. Park A.J., Collins J., Blennerhassett P.A., Ghia J.E., Verdu E.F., Bercik P., et al. Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol Motil 2013, 25. 733-e575.
173. Dinan T.G., Cryan J.F. Melancholic microbes: a link between gut microbiota and depression?. Neurogastroenterol Motil 2013, 25:713-719.
174. Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011, 108:16050-16055.
175. Messaoudi M., Lalonde R., Violle N., Javelot H., Desor D., Nejdi A., et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011, 105:755-764.
176. Soczynska J.K., Mansur R.B., Brietzke E., Swardfager W., Kennedy S.H., Woldeyohannes H.O., et al. Novel therapeutic targets in depression: minocycline as a candidate treatment. Behav Brain Res 2012, 235:302-317.
177. Miyaoka T., Wake R., Furuya M., Liaury K., Ieda M., Kawakami K., et al. Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuro-psychopharmacol Biolog Psychiatry 2012, 37:222-226.
178. Mello B.S., Monte A.S., McIntyre R.S., Soczynska J.K., Custodio C.S., Cordeiro R.C., et al. Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration. J Psychiatric Res 2013, 47:1521-1529.
179. Zemke D., Majid A. The potential of minocycline for neuroprotection in human neurologic disease. Clin Neuropharmacol 2004, 27:293-298.
180. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009, 14:511-522.
181. Naseribafrouei A., Hestad K., Avershina E., Sekelja M., Linlokken A., Wilson R., et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 2014.
182. Gareau M.G., Wine E., Rodrigues D.M., Cho J.H., Whary M.T., Philpott D.J., et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011, 60:307-317.
183. Desbonnet L., Clarke G., Shanahan F., Dinan T.G., Cryan J.F. Microbiota is essential for social development in the mouse. Mol Psychiatry 2013.
184. Li W., Dowd S.E., Scurlock B., Acosta-Martinez V., Lyte M. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav 2009, 96:557-567.
185. Ohland C.L., Kish L., Bell H., Thiesen A., Hotte N., Pankiv E., et al. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology 2013, 38:1738-1747.
186. Kiser D., Steemers B., Branchi I., Homberg J.R. The reciprocal interaction between serotonin and social behaviour. Neurosci Biobehav Rev 2012, 36:786-798.
187. Homberg J.R. Serotonin and decision making processes. Neurosci Biobehav Rev 2012, 36:218-236.
188. Bajaj J.S., Ridlon J.M., Hylemon P.B., Thacker L.R., Heuman D.M., Smith S., et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol -Gastrointestinal Liver Physiol 2012, 302:G168-G175.
189. Strauss E., da Costa M.F. The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology 1998, 45:900-904.
190. Kennedy P.J., Clarke G., Quigley E.M., Groeger J.A., Dinan T.G., Cryan J.F. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev 2012, 36:310-340.
191. Tkachuk G.A., Graff L.A., Martin G.L., Bernstein C.N. Randomized controlled trial of cognitive-behavioral group therapy for irritable bowel syndrome in a medical setting. J Clin Psychol Med Settings 2003, 10:57-69.
192. Toner B.B., Segal Z.V., Emmott S., Myran D., Ali A., DiGasbarro I., et al. Cognitive-behavioral group therapy for patients with irritable bowel syndrome. Int J Group Psychotherapy 1998, 48:215-243.
193. Kennedy P.J., Clarke G., O'Neill A., Groeger J.A., Quigley E.M., Shanahan F., et al. Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory. Psychol Med 2013, 1-14.
194. Aizawa E., Sato Y., Kochiyama T., Saito N., Izumiyama M., Morishita J., et al. Altered cognitive function of prefrontal cortex during error feedback in patients with irritable bowel syndrome, based on FMRI and dynamic causal modeling. Gastroenterology 2012, 143:1188-1198.
195. Desbonnet L., Garrett L., Clarke G., Kiely B., Cryan J.F., Dinan T.G. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010, 170:1179-1188.
196. Tillisch K., Labus J., Kilpatrick L., Jiang Z., Stains J., Ebrat B., et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013, 144:1394-1401. 401 e1-4.
197. Bell C.J., Hood S.D., Nutt D.J. Acute tryptophan depletion. Part II: clinical effects and implications. Aust New Zealand J Psychiatry 2005, 39:565-574.
198. Azpiroz F., Bouin M., Camilleri M., Mayer E.A., Poitras P., Serra J., et al. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007, 19:62-88.
199. Barbara G., Cremon C., De Giorgio R., Dothel G., Zecchi L., Bellacosa L., et al. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep 2011, 13:308-315.
200. Labus J.S., Dinov I.D., Jiang Z., Ashe-McNalley C., Zamanyan A., Shi Y., et al. Irritable bowel syndrome in female patients is associated with alterations in structural brain networks. Pain 2014, 155:137-149.
201. Mertz H., Morgan V., Tanner G., Pickens D., Price R., Shyr Y., et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000, 118:842-848.
202. Fukudo S. Stress and visceral pain: focusing on irritable bowel syndrome. Pain 2013, 154(Suppl. 1):S63-S70.
203. Bueno L., Fioramonti J., Delvaux M., Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997, 112:1714-1743.
204. Mayer E.A., Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med 2011, 62:381-396.
205. O'Mahony S., Chua A.S., Quigley E.M., Clarke G., Shanahan F., Keeling P.W., et al. Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model. Neurogastroenterol Motil 2008, 20:680-688.
206. O'Mahony S.M., Bulmer D.C., Coelho A.M., Fitzgerald P., Bongiovanni C., Lee K., et al. 5-HT(2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction. Neurogastroenterol Motil 2010, 22:573-578. e124.
207. Bonaz B., Baciu M., Papillon E., Bost R., Gueddah N., Le Bas J.F., et al. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol 2002, 97:654-661.
208. Drossman D.A., Ringel Y., Vogt B.A., Leserman J., Lin W., Smith J.K., et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology 2003, 124:754-761.
209. Stasi C., Rosselli M., Bellini M., Laffi G., Milani S. Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol 2012, 47:1177-1185.
210. Suzuki R., Rygh L.J., Dickenson A.H. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 2004, 25:613-617.
211. Danzebrink R.M., Gebhart G.F. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat. Brain Res 1991, 538:64-75.
212. Kozlowski C.M., Green A., Grundy D., Boissonade F.M., Bountra C. The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat. Gut 2000, 46:474-480.
213. Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil 2007, 19(Suppl. 2):25-31.
214. Camilleri M., Andrews C.N., Bharucha A.E., Carlson P.J., Ferber I., Stephens D., et al. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 2007, 132:17-25.
215. Cremon C., Carini G., Wang B., Vasina V., Cogliandro R.F., De Giorgio R., et al. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol 2011, 106:1290-1298.
216. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541-551.
217. Cassani E., Privitera G., Pezzoli G., Pusani C., Madio C., Iorio L., et al. Use of probiotics for the treatment of constipation in Parkinson's disease patients. Minerva Gastroenterol Dietol 2011, 57:117-121.
218. Wall R., Ross R.P., Ryan A.C., Hussey S., Murphy B., Fitzgerald G.F., et al. Role of gut microbiota in early infant development. Clin Med Pediatr 2009, 3:45-54.
219. O'Mahony S.M., Savignac H.M., O'Brien T., Scully P., Quigley E.M., Marchesi J., O'Toole P.W., Dinan T.G., Cryan J.F. Early-life dysbiosis-induced visceral hypersensitivity in adulthood. Gastroenterology 2010, 138:S4-S5.
220. Verdu E.F., Bercik P., Verma-Gandhu M., Huang X.X., Blennerhassett P., Jackson W., et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006, 55:182-190.
221. Gaykema R.P., Goehler L.E., Lyte M. Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav Immun 2004, 18:238-245.
222. Rousseaux C., Thuru X., Gelot A., Barnich N., Neut C., Dubuquoy L., et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Med 2007, 13:35-37.
223. McKernan D.P., Fitzgerald P., Dinan T.G., Cryan J.F. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil 2010, 22:1029-1035. e268.
224. Clarke G., Cryan J.F., Dinan T.G., Quigley E.M. Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria. Aliment Pharmacol Ther 2012, 35:403-413.
225. Bercik P., Collins S.M., Verdu E.F. Microbes and the gut-brain axis. Neurogastroenterol Motil 2012, 24:405-413.
226. Grover M., Drossman D.A. Centrally acting therapies for irritable bowel syndrome. Gastroenterol Clin North Am 2011, 40:183-206.
227. Terron J.A. Novel insights into the potential involvement of 5-HT7 receptors in endocrine dysregulation in stress-related disorders. Rev Neurosci 2014.
228. Bueno L., de Ponti F., Fried M., Kullak-Ublick G.A., Kwiatek M.A., Pohl D., et al. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil 2007, 19:89-119.
229. Bomholt S.F., Mikkelsen J.D., Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 2005, 48:252-263.
230. Brennan B.P., Fogarty K.V., Roberts J.L., Reynolds K.A., Pope H.G., Hudson J.I. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. Hum Psychopharmacol 2009, 24:423-428.
231. Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 2009, 16:53-59.
232. Gershon M.D. Serotonin: its role and receptors in enteric neurotransmission. Adv Exp Med Biol 1991, 294:221-230.
233. Chey W.D., Chey W.Y., Heath A.T., Dukes G.E., Carter E.G., Northcutt A., et al. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2004, 99:2195-2203.
234. McLean P.G., Borman R.A., Lee K. 5-HT in the enteric nervous system: gut function and neuropharmacology. Trends Neurosci 2007, 30:9-13.
235. Tack J., Muller-Lissner S., Bytzer P., Corinaldesi R., Chang L., Viegas A., et al. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation. Gut 2005, 54:1707-1713.
236. Crowell M.D., Wessinger S.B. 5-HT and the brain-gut axis: opportunities for pharmacologic intervention. Expert Opin Investig Drugs 2007, 16:761-765.
237. Gershon M.D., Liu M.T. Serotonin and neuroprotection in functional bowel disorders. Neurogastroenterol Motil 2007, 19(Suppl. 2):19-24.
238. Quigley E.M., Craig O.F. Irritable bowel syndrome; update on pathophysiology and management. Turk J Gastroenterol 2012, 23:313-322.
239. Chey W.D., Maneerattaporn M., Saad R. Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. Gut Liver 2011, 5:253-266.
240. Ohashi-Doi K., Himaki D., Nagao K., Kawai M., Gale J.D., Furness J.B., et al. A selective, high affinity 5-HT 2B receptor antagonist inhibits visceral hypersensitivity in rats. Neurogastroenterol Motil 2010, 22:e69-e76.
241. Camilleri M. LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin. Neurogastroenterol Motil 2011, 23:193-200.
242. Dinan T.G., Stanton C., Cryan J.F. Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013, 74:720-726.
243. Luo J., Wang T., Liang S., Hu X., Li W., Jin F. Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat. Sci China Life Sci 2014, 57:327-335.
244. Ozogul F., Kuley E., Ozogul Y., Ozogul I. The function of lactic acid bacteria on biogenic amines production by food-borne pathogens in arginine decarboxylase broth. Food Sci Technol Res 2012, 18:795-804.
245. Shishov V.A., Kirovskaya T.A., Kudrin V.S., Oleskin A.V. Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12. Appl Biochem Micro+ 2009, 45:494-497.
246. Ozogul F. Production of biogenic amines by Morganella morganii, Klebsiella pneumoniae and Hafnia alvei using a rapid HPLC method. Eur Food Res Technol 2004, 219:465-469.
247. Mohammad-Zadeh L.F., Moses L., Gwaltney-Brant S.M. Serotonin: a review. J Vet Pharmacol Therap 2008, 31:187-199.